Biontech Se Revenue per Employee (BNTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Biontech Se  (NASDAQ: BNTX)
 

Biontech Se's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 4.32% in the fourth quarter 2025, year on year to cumulative value of $3,214 million, Biontech Se's revenue per employee grew on a trailing twelve months basis to $ 411,719. The productivity of Biontech Se's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 245 other companies have achieved higher revenue per employee. While Biontech Se's total ranking has deteriorated compared to the previous quarter from 0 to 2085. Biontech Se has 7,807 employees.


What is Sales per Employee Ratio?







BNTX Revenue per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 4.32 % - - - -27.96 %
Sales per Employee (TTM) $ 411,719 394,676 394,676 394,676 394,676
BNTX's Total Ranking # 2085 # 0 # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 34
Healthcare Sector # 246
Overall Market # 2085

Revenue per Employee Statistics
High Average Low
$ 547,878 $ 287,809 $ 15,578
(Dec 31 2023)   (Dec 31 2019)



Financial Statements
Biontech Se's Revenue MRQ $ 3,214 Millions Visit BNTX's Income Statement
Biontech Se's Revenues TTM $ 3,214 Millions Visit BNTX's aggregate revenue growth
What are BNTX's Sales? Visit BNTX's Sales by Segment




Other Ratios
Biontech Se's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BNTX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BNTX's Competitors
Revenue per Employee for BNTX's Suppliers
Revenue per Employee for BNTX's Customers

You may also want to know
BNTX's Sales Growth Rates BNTX's Pe Price to earnings ratio BNTX's Receivables Turnover Ratio BNTX's Stock Quote
BNTX's Net Income Growth Rates BNTX's Ps Price to Sales ratio BNTX's Sales per Employee BNTX's Asset Turnover Ratio
BNTX's Net Margin BNTX's Pb Price to Book ratio BNTX's Financial Strength Ratios BNTX's Dividend Payout Ratio
Date modified: 2026-07-07T09:38:01+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Alkermes Plc   719,950.73 $ 1,475.899  Million 2,050 
Telix Pharmaceuticals Ltd  717,673.21 $ 803.794  Million 1,120 
Cerus Corporation  712,805.56 $ 205.288  Million 288 
Geron Corporation  711,717.05 $ 183.623  Million 258 
Marker Therapeutics inc   709,333.80 $ 3.547  Million
Harrow Inc   708,997.38 $ 270.837  Million 382 
Astrazeneca Plc  706,847.17 $ 58,739.000  Million 83,100 
Hutchmed china Limited  703,220.51 $ 548.512  Million 780 
Evofem Biosciences Inc   695,965.52 $ 20.183  Million 29 
Aveanna Healthcare Holdings Inc   695,199.71 $ 2,433.199  Million 3,500 
Inventiva S a   694,904.00 $ 13.898  Million 20 
Vericel Corporation  694,118.09 $ 276.259  Million 398 
Masimo Corp  693,727.27 $ 1,526.200  Million 2,200 
Axsome Therapeutics Inc   690,265.95 $ 638.496  Million 925 
Inspire Medical Systems inc   683,988.00 $ 911.756  Million 1,333 
Option Care Health Inc   683,389.18 $ 5,648.895  Million 8,266 
Elutia Inc   678,423.08 $ 17.639  Million 26 
Transmedics Group Inc   674,269.49 $ 605.494  Million 898 
Johnson and Johnson  668,984.38 $ 94,193.000  Million 140,800 
Organogenesis Holdings Inc   660,619.44 $ 564.169  Million 854 
Zoetis Inc   652,896.55 $ 9,467.000  Million 14,500 
Premier Air Charter Holdings Inc   650,561.39 $ 31.878  Million 49 
Veracyte Inc   648,386.75 $ 489.532  Million 755 
Cardiff Lexington Corporation  640,865.39 $ 11.536  Million 18 
Karyopharm Therapeutics Inc   640,644.74 $ 146.067  Million 228 
Organon and Co   622,800.00 $ 6,228.000  Million 10,000 
Biolife Solutions Inc   620,116.13 $ 96.118  Million 155 
Dyadic International Inc   618,069.00 $ 3.090  Million
Lexicon Pharmaceuticals Inc   614,851.85 $ 49.803  Million 81 
Bioventus Inc   603,026.60 $ 566.845  Million 940 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.